Treatment with Brusatol inhibits oncogenic transcription factors NRF2 and TAZ, reducing glioma stem cells survival.
Keyword(s):
Keyword(s):
2014 ◽
Vol 20
(1)
◽
pp. 66-72
◽
2015 ◽
Vol 9
(2)
◽
pp. 70-77